BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24262603)

  • 21. Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain.
    Balas L; Risé P; Gandrath D; Rovati G; Bolego C; Stellari F; Trenti A; Buccellati C; Durand T; Sala A
    J Med Chem; 2019 Nov; 62(21):9961-9975. PubMed ID: 31626541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents.
    Tungen JE; Aursnes M; Ramon S; Colas RA; Serhan CN; Olberg DE; Nuruddin S; Willoch F; Hansen TV
    Org Biomol Chem; 2018 Sep; 16(36):6818-6823. PubMed ID: 30204204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA.
    Liu M; Chen P; Véricel E; Lelli M; Béguin L; Lagarde M; Guichardant M
    J Lipid Res; 2013 Aug; 54(8):2083-2094. PubMed ID: 23740966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total Synthesis of the Antidiabetic (Type 2) Lipid Mediator Protectin DX/PDX.
    Sancéau JY; Maltais R; Poirier D; Marette A
    J Org Chem; 2019 Jan; 84(2):495-505. PubMed ID: 30586310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
    Chiang N; Serhan CN
    Methods Mol Biol; 2006; 341():227-50. PubMed ID: 16799203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights in diabetes: Molecular mechanisms-Protectin DX, an anti-inflammatory and a stimulator of inflammation resolution metabolite of docosahexaenoic acid, protects against the development of streptozotocin-induced type 1 and type 2 diabetes mellitus in male Swiss albino mice.
    Rengachar P; Polavarapu S; Das UN
    Front Endocrinol (Lausanne); 2022; 13():1053879. PubMed ID: 36778598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1
    Nesman JI; Gangestad Primdahl K; Tungen JE; Palmas F; Dalli J; Hansen TV
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31491851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering.
    Ariel A; Li PL; Wang W; Tang WX; Fredman G; Hong S; Gotlinger KH; Serhan CN
    J Biol Chem; 2005 Dec; 280(52):43079-86. PubMed ID: 16216871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protectin DX as a therapeutic strategy against frailty in mice.
    Perazza LR; Gower AC; Brown-Borg HM; Pajevic PD; Thompson LV
    Geroscience; 2023 Aug; 45(4):2601-2627. PubMed ID: 37059838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-effect and metabolism of docosahexaenoic acid: pathophysiological relevance in blood platelets.
    Lagarde M; Calzada C; Guichardant M; Véricel E
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):49-52. PubMed ID: 22520055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging role of docosahexaenoic acid in neuroinflammation.
    Orr SK; Bazinet RP
    Curr Opin Investig Drugs; 2008 Jul; 9(7):735-43. PubMed ID: 18600579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator.
    Aursnes M; Tungen JE; Vik A; Dalli J; Hansen TV
    Org Biomol Chem; 2014 Jan; 12(3):432-7. PubMed ID: 24253202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases.
    Chen Y; Wang J; Nie R; Zhou S
    Med Hypotheses; 2008 Aug; 71(2):237-40. PubMed ID: 18448265
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Ariyoshi T; Hagihara M; Eguchi S; Fukuda A; Iwasaki K; Oka K; Takahashi M; Yamagishi Y; Mikamo H
    Front Microbiol; 2020; 11():587725. PubMed ID: 33193245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice.
    Yamada T; Tani Y; Nakanishi H; Taguchi R; Arita M; Arai H
    FASEB J; 2011 Feb; 25(2):561-8. PubMed ID: 20959515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis.
    Marcon R; Bento AF; Dutra RC; Bicca MA; Leite DF; Calixto JB
    J Immunol; 2013 Oct; 191(8):4288-98. PubMed ID: 24038091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis.
    Hong S; Tjonahen E; Morgan EL; Lu Y; Serhan CN; Rowley AF
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):107-16. PubMed ID: 16303609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolvin D1 and its GPCRs in resolution circuits of inflammation.
    Recchiuti A
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():64-76. PubMed ID: 23500003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediator lipidomics in ophthalmology: targets for modulation in inflammation, neuroprotection and nerve regeneration.
    Gordon WC; Bazan NG
    Curr Eye Res; 2013 Oct; 38(10):995-1005. PubMed ID: 23981028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.